Home Canadian Tech At the Leading Edge Innovator Spotlight: Industry partnerships at core of unique BIOTIC model

Innovator Spotlight: Industry partnerships at core of unique BIOTIC model

Innovator Spotlight: Industry partnerships at core of unique BIOTIC model

When the National Research Council (NRC) announced a restructuring in 2012, the potential for the loss of key research capabilities in Atlantic Canada was a real possibility. But in true Atlantic Canadian fashion, the industry came together to look at the opportunity and, through that process, BIOTIC was born.

BIOTIC (BIOmedical Translational Imaging Centre) is a multi-site imaging centre that is embedded in the two leading research and teaching hospitals in Nova Scotia.

A core research facility of the health centres, BIOTIC provides expertise in all facets of imaging R&D and collaborates on commercial development projects with industry partners as well as R&D projects with a number of institutions.

Another shining example of the growing success coming out of Atlantic Canada’s bio and life-sciences sector is BIOTIC’s unique partnership model to research. It’s a model that just doesn’t exist in other markets.

“For us it’s not all about the equipment and experts,” says Denise LaLanne, Biotic Director of Innovation Services. “We marry together the cutting-edge technology with a project management philosophy that allows companies to move ideas forward. A key part of our difference is that industry partnership is at the core of how we are structured.”

This entrepreneurial and collaborative spirit allows BIOTIC to work with some of the leading bio and life-science companies in the world.

Heather Chalmers, General Manager for GE Healthcare Canada says their collaboration with BIOTIC is able to draw on the considerable expertise in Nova Scotia to improve patient care for the province and potentially the world.

“GE Healthcare is keen to invest in collaborations that draw on the best capabilities from Canada’s leading healthcare providers and research organizations to help commercialize products with the potential to advance our understanding and treatment of disease.”

For BIOTIC, the key is continuing to use its research to apply the technology and translate that into changes that benefit healthcare.

“The long-term opportunities are very broad,” says BIOTIC’s Science Lead, Dr. Steven Beyea. “From more accurate diagnosis to improved economics through a reduction in healthcare costs, these new technologies show signs of helping to change the way we deliver healthcare.


Please enter your comment!
Please enter your name here